SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-061431
Filing Date
2021-12-28
Accepted
2021-12-28 16:17:23
Documents
12
Period of Report
2021-12-27
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K isco-8k_20211227.htm   iXBRL 8-K 35398
  Complete submission text file 0001564590-21-061431.txt   149063

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA isco-20211227.xsd EX-101.SCH 5737
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20211227_lab.xml EX-101.LAB 16541
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20211227_pre.xml EX-101.PRE 9801
6 EXTRACTED XBRL INSTANCE DOCUMENT isco-8k_20211227_htm.xml XML 3054
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 211525164
SIC: 2834 Pharmaceutical Preparations